Moreover, some studies reported that METTL14 represses colorectal cancer (CRC) development via the PI3K/Akt signaling, upregulated by brain-derived neurotrophic factor (BDNF), which revealed similar evidence with our GO results. This evidence concerns the gene METTL14 and colorectal cancer.